Search research articles
Contact Us
Filters
Showing results (11-20 of 13) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 13 results.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 18, 2017
<sup>11</sup>C-PBR28 and <sup>18</sup>F-PBR111 Detect White Matter Inflammatory Heterogeneity in Multiple Sclerosis
Gourab Datta, Alessandro Colasanti, Nicola Kalk, et al.
Nature Communications
|
May 1, 2025
Ucenprubart is an agonistic antibody to CD200R with the potential to treat inflammatory skin disease: preclinical development and a phase 1 clinical study
Anja Koester, Derrick R Witcher, Mark Lee, et al.
Clinical Pharmacology and Therapeutics
|
August 29, 2021
First-in-Human Study of Bamlanivimab in a Randomized Trial of Hospitalized Patients With COVID-19
Peter Chen, Gourab Datta, Ying Grace Li, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 13) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 13 results.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 18, 2017
<sup>11</sup>C-PBR28 and <sup>18</sup>F-PBR111 Detect White Matter Inflammatory Heterogeneity in Multiple Sclerosis
Gourab Datta, Alessandro Colasanti, Nicola Kalk, et al.
Nature Communications
|
May 1, 2025
Ucenprubart is an agonistic antibody to CD200R with the potential to treat inflammatory skin disease: preclinical development and a phase 1 clinical study
Anja Koester, Derrick R Witcher, Mark Lee, et al.
Clinical Pharmacology and Therapeutics
|
August 29, 2021
First-in-Human Study of Bamlanivimab in a Randomized Trial of Hospitalized Patients With COVID-19
Peter Chen, Gourab Datta, Ying Grace Li, et al.
Page
of 2